Company Information

  

Address: FIFTH FLOOR, WATERLOO EXCHANGE
WATERLOO ROAD 
City: DUBLIN 
State:  
Zip Code: 4 
Telephone: 353-1-634-7800 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

Jazz Pharmaceuticals plc is an international biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing meaningful products that address unmet medical needs. We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology. Our lead marketed products are: * Xyrem® (sodium oxybate) oral solution, the only product approved by the U.S. Food and Drug Administration, or FDA, and marketed in the U.S. for the treatment of both cataplexy and excessive daytime sleepiness, or EDS, in patients with narcolepsy; * Erwinaze® (asparaginase Erwinia chrysanthemi), a treatment approved in the U.S. and in certain markets in Europe (where it is marketed as Erwinase®) for patients with acute lymphoblastic leukemia, or ALL, who have developed hypersensitivity to E.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
12/20177.96NA16.92
09/20176.07NA24.09
06/20176.49NA23.96
03/20176.76NA21.47
12/20166.41NA17.01
09/20165.72NA21.24
06/20165.69NA24.83
03/20165.30NA24.63

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2017 Leverage 2017
Net Inc/Comm Equity0.25Total Liab/Total Assets0.47
Net Inc/Total Assets0.10Total Liab/Inv Cap0.50
Net Inc/Inv Cap0.10Total Liab/Comm Equity1.25
Pretax Inc/Net Sales0.27Interest Coverage Ratio6.67
Net Inc/Net Sales0.30Curr Debt/Equity0.01
Cash Flow/Net Sales0.43LTD/Equity0.57
SG&A/NetSales0.34Total Debt/Equity0.58
Asset Utilization   Liquidity  
Net Receivables Turnover7.06Quick Ratio3.15
Inventory Turnover2.85Current Ratio3.29
Inventory Day Sales0.01Net Rec/Curr Assets0.23
Net Sales/Work Cap2.40Inv/Curr Assets0.04
Net Sales/PP&E9.52  

Income Statement (Millions)

  12/31/2017 9/30/2017 6/30/2017 3/31/2017
Total Revenues(Net Sales) 436.40 411.86 394.39 376.05
Cost of Goods Sold 25.25 31.20 28.67 25.07
Selling & Admin Exps 143.05 124.52 132.33 144.26
Operating Income 141.21 86.45 165.04 136.14
Interest Exp 21.43 19.19 18.29 18.84
Pretax Income 118.93 65.04 141.32 115.83
Other Income -0.85 -2.22 -5.43 -1.46
Net Income Bef Extraordinary ... NA NA NA NA
Net Income 232.21 63.53 105.60 86.51

Balance Sheet (Millions)

Assets 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Cash & Short Term Investments 601.04 452.62 319.21 407.00
Receivables - Total 224.13 258.62 238.75 243.04
Inventories - Total 43.25 41.34 39.66 37.65
Total Current Assets 968.28 830.94 662.50 752.85
Net Property, Plant & Equipment 170.08 159.39 136.63 119.91
Total Assets 5,123.67 4,999.02 4,804.02 4,815.82
Liabilities        
Accounts Payable 244.72 223.47 205.72 248.09
Debt in Current Liabilities 40.61 36.09 36.09 136.09
Total Current Liabilities 293.95 268.18 250.39 392.77
Long-Term Debt 1,540.43 1,543.82 1,635.80 1,739.59
Total Liabilities 2,410.58 2,529.73 2,602.99 2,831.84
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.01 0.01 0.01 0.01
Retained Earnings 917.96 728.12 690.16 601.52
Treasury Stock NA NA NA NA
Total Stockholders' Equity 2,713.10 2,469.30 2,201.03 1,983.99
Total Liabilities and Stockholders' Equity 5,123.67 4,999.02 4,804.02 4,815.82

Cash Flow Summary (Millions)

Categories 12/31/2017 9/30/2017 6/30/2017 3/31/2017
Net Cash Provided by Operating Activities 204.56 188.90 135.09 164.54
Net Cash Provided by Investing Activities -31.88 -203.35 -30.15 -3.57
Net Cash Provided by Financing Activities -39.98 27.03 -214.48 -181.67

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/2013872.42216.313.51
12/20141,172.8858.390.93
12/20151,324.80329.545.23
12/20161,487.97396.836.41
12/20171,618.69487.857.96
Growth Rates16.7122.5522.72

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional03/31/1836554,48691.11




Report Date : 4/16/2018

Powered By Edgar Online © 2018EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.